Blog
FDA Gluten Review, Virginia Allergy Labels, and New Celiac Research | The Gluten-Free Brief
June’s gluten-free news: FDA’s labeling review, Virginia’s takeout law, beer testing gaps, a probiotic yeast study, and recalls in three countries.
Celiac Disease, Mortality Risk, and the New Celiac Safety Act | The Gluten-Free Brief
Celiac disease raises the risk of death, heart disease, and organ failure — and two new studies published this week put the numbers on paper for the first time in the U.S. This edition also covers a landmark labeling bill, a stalled compensation law in Spain, and how major league baseball is stepping up for the celiac community.
The Gluten-Free Brief – May 22, 2026
Celiac disease raises the risk of eating disorders, a new drug shows effects beyond the gut, and a popular podcast reminded us why awareness still matters. This edition covers the latest research, recalls, and what the celiac community is talking about right now.
The Gluten-Free Brief – May 7, 2026
The latest edition of The Gluten-Free Brief covers major new celiac research, undiagnosed case estimates from Ireland, Québec, and the UK, gluten-related recalls in Canada, a U.S. court ruling on gluten-free meals, and formulation changes affecting Peanut M&M’s in New Zealand.
Myth or Fact? Is Rice Always Gluten Free?
Rice is naturally gluten free — but that doesn’t always mean safe. A look at what the science actually says about rice, contamination risk, and what certified gluten free really means for processed rice products.
The Gluten-Free Brief – April 22, 2026
How old are celiac risk genes, is kissing after gluten really safe, and which products were just recalled? This edition of the Gluten-Free Brief has the science, the alerts, and the good news.
Have questions or not sure where to start?
Contact us to speak with a representative or receive a no-obligation quote. Our staff is available anytime to answer questions and help navigate the decisions toward achieving gluten-free certification for your company.
